<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="73066461412 doi: 10.1186/s12931-020-01412-1 : Research Predictive factors of severe coronavirus" exact="disease" post="2019 in previously healthy young adults: a single-center, retrospective"/>
 <result pre="a single-center, retrospective study ZhouChangzhizczcz6655@sina.com1HuangZhehuangzhekkx@126.com2TanWeijun270112348@qq.com1LiXueying404471371@qq.com1YinWenevan_wen@126.com1XiaoYangxy821112@sina.com1TaoZhaowuzhaowu513@163.com1GengShuanggengshuangsky@126.com1HuYihuyi_resp@sina.com1[1], grid.33199.310000 0004 0368 7223Department of" exact="Respiratory" post="and Critical Care Medicine, The Central Hospital of Wuhan,"/>
 <result pre="0004 0368 7223Department of Respiratory and Critical Care Medicine, The" exact="Central" post="Hospital of Wuhan, Tongji Medical College, Huazhong University of"/>
 <result pre="and Technology, [2], grid.33199.310000 0004 0368 7223Cardiac Function Department, The" exact="Central" post="Hospital of Wuhan, Tongji Medical College, Huazhong University of"/>
 <result pre="Abstract Background Several previously healthy young adults have developed Coronavirus" exact="Disease" post="2019 (COVID-19), and a few of them progressed to"/>
 <result pre="classified as having mild or severe COVID-19 based on their" exact="respiratory" post="rate, SpO2, and PaO2/FiO2 levels. Patientsâ€™ symptoms, computer tomography"/>
 <result pre="enrolled into logistic regression model to predict the factors affecting" exact="disease" post="severity. A receiver operating characteristic (ROC) curve was applied"/>
 <result pre="(CI) 0.704â€&quot;0.877)(PÂ Conclusion For previously healthy young adults with COVID-19," exact="lymphopenia" post="on admission can predict severe prognosis. Keywords COVID-19 SARS-CoV-2"/>
 <result pre="Retrospective study Background From December 2019 to March 2020, coronavirus" exact="disease" post="2019 (COVID-19) has been considered an epidemic in China,"/>
 <result pre="in China, specifically in Wuhan City, Hubei Province, where this" exact="disease" post="initially emerged [1]. According to data, this disease has"/>
 <result pre="where this disease initially emerged [1]. According to data, this" exact="disease" post="has already been considered a global epidemic because more"/>
 <result pre="970,000 patients infected and 50,000+ deaths [2]. Hence, the severe" exact="acute" post="respiratory syndrome coronavirus-2 (SARS-CoV-2) which caused COVID-19, shows stronger"/>
 <result pre="patients infected and 50,000+ deaths [2]. Hence, the severe acute" exact="respiratory" post="syndrome coronavirus-2 (SARS-CoV-2) which caused COVID-19, shows stronger infectivity"/>
 <result pre="infected and 50,000+ deaths [2]. Hence, the severe acute respiratory" exact="syndrome" post="coronavirus-2 (SARS-CoV-2) which caused COVID-19, shows stronger infectivity than"/>
 <result pre="caused COVID-19, shows stronger infectivity than SARS-CoV and Middle East" exact="respiratory" post="syndrome (MERS)-CoV, although, the mortality rate of COVID-19 is"/>
 <result pre="COVID-19, shows stronger infectivity than SARS-CoV and Middle East respiratory" exact="syndrome" post="(MERS)-CoV, although, the mortality rate of COVID-19 is lower"/>
 <result pre="respiratory syndrome (MERS)-CoV, although, the mortality rate of COVID-19 is" exact="lower" post="than SARS and MERS [3]. Nevertheless, COVID-19 should be"/>
 <result pre="previous study has reported that elderly men, specifically those with" exact="chronic" post="comorbidities, tend to develop a more severe COVID-19 which"/>
 <result pre="considering that these elderly men have impaired immune response and" exact="incomplete" post="functional organs. However, several previously healthy young adults who"/>
 <result pre="design We conducted a retrospective study in a single-center, the" exact="Central" post="Hospital of Wuhan. Moreover, this hospital was one of"/>
 <result pre="that admitted COVID-19 patients in Wuhan in December 2019. A" exact="total" post="of 425 patients were included in this study from"/>
 <result pre="considered previously healthy adults. (Fig.Â 1) Our exclusion criteria included" exact="chronic" post="diseases: hypertension, diabetes, coronary heart disease, chronic cerebrovascular disease,"/>
 <result pre="(Fig.Â 1) Our exclusion criteria included chronic diseases: hypertension, diabetes," exact="coronary heart disease," post="chronic cerebrovascular disease, chronic respiratory disease (asthma, COPD), chronic"/>
 <result pre="1) Our exclusion criteria included chronic diseases: hypertension, diabetes, coronary" exact="heart" post="disease, chronic cerebrovascular disease, chronic respiratory disease (asthma, COPD),"/>
 <result pre="exclusion criteria included chronic diseases: hypertension, diabetes, coronary heart disease," exact="chronic" post="cerebrovascular disease, chronic respiratory disease (asthma, COPD), chronic hepatitis,"/>
 <result pre="criteria included chronic diseases: hypertension, diabetes, coronary heart disease, chronic" exact="cerebrovascular disease," post="chronic respiratory disease (asthma, COPD), chronic hepatitis, and other"/>
 <result pre="chronic diseases: hypertension, diabetes, coronary heart disease, chronic cerebrovascular disease," exact="chronic" post="respiratory disease (asthma, COPD), chronic hepatitis, and other chronic"/>
 <result pre="diseases: hypertension, diabetes, coronary heart disease, chronic cerebrovascular disease, chronic" exact="respiratory" post="disease (asthma, COPD), chronic hepatitis, and other chronic diseases"/>
 <result pre="hypertension, diabetes, coronary heart disease, chronic cerebrovascular disease, chronic respiratory" exact="disease" post="(asthma, COPD), chronic hepatitis, and other chronic diseases that"/>
 <result pre="heart disease, chronic cerebrovascular disease, chronic respiratory disease (asthma, COPD)," exact="chronic hepatitis," post="and other chronic diseases that can affect the immune"/>
 <result pre="disease, chronic respiratory disease (asthma, COPD), chronic hepatitis, and other" exact="chronic" post="diseases that can affect the immune status. They were"/>
 <result pre="fever (the highest temperature recorded), cough, expectoration, headache, wheezing, weakness," exact="muscle" post="ache, pharyngalgia, runny nose, anorexia, stethalgia, chest tightness, dyspnea,"/>
 <result pre="temperature recorded), cough, expectoration, headache, wheezing, weakness, muscle ache, pharyngalgia," exact="runny nose," post="anorexia, stethalgia, chest tightness, dyspnea, and diarrhea were assessed."/>
 <result pre="headache, wheezing, weakness, muscle ache, pharyngalgia, runny nose, anorexia, stethalgia," exact="chest" post="tightness, dyspnea, and diarrhea were assessed. Time from illness"/>
 <result pre="ache, pharyngalgia, runny nose, anorexia, stethalgia, chest tightness, dyspnea, and" exact="diarrhea" post="were assessed. Time from illness onset to hospital admission"/>
 <result pre="onset to hospital admission (days), computed tomography (CT) scan revealing" exact="bilateral" post="lesion or unilateral lesion, and preadmission drugs used were"/>
 <result pre="admission (days), computed tomography (CT) scan revealing bilateral lesion or" exact="unilateral" post="lesion, and preadmission drugs used were also evaluated. While"/>
 <result pre="blood examination. Levels of creatinine (Cr), blood urea nitrogen (BUN)," exact="total" post="bilirubin (TBIL), direct bilirubin (DBIL), indirect bilirubin (IBIL), albumin"/>
 <result pre="with severe COVID-19 if they presented with (a) dyspnea with" exact="respiratory" post="rateâ€‰â‰¥â€‰30 breaths/min, (b) finger oxygen saturationâ€‰â‰¤â€‰93% at resting state,"/>
 <result pre="(b) finger oxygen saturationâ€‰â‰¤â€‰93% at resting state, and (c) arterial" exact="partial" post="pressure of oxygen/fractional concentration of inspired oxygen â‰¤300â€‰mmHg (1â€‰mmHgâ€‰=â€‰0.133â€‰kPa)"/>
 <result pre="Results Demographic characteristics Based on the data we collected, a" exact="total" post="of 28 out of the 123 (22.76%) previously healthy"/>
 <result pre="developed severe COVID-19. Of those 28, 20 patients of severe" exact="disease" post="were diagnosed with the PaO2/FiO2â€‰â‰¤â€‰300â€‰mmHg, four patients were classified"/>
 <result pre="in resting time. All patients received appropriate treatment, and severe" exact="disease" post="patients received oxygen therapy. Sixteen patients received routine nasal"/>
 <result pre="patients were male. All patients were residents of Wuhan City." exact="Fever" post="was the most common symptom (79.7%), followed by cough"/>
 <result pre="and weakness (40.7%). Pharyngalgia (9.8%), stethalgia (8.1%), dyspnea (5.7%), and" exact="runny nose" post="(1.6%) were rarely observed in previously healthy young patients"/>
 <result pre="admission. The symptoms observed between the two groups were compared." exact="Severe" post="patients were observed to experience fever more (96.2% vs."/>
 <result pre="patients. Most CT photographs showed a few ground-glass opacities (GGO)" exact="bilateral" post="or unilateral. We compared the bilateral lesion of the"/>
 <result pre="few ground-glass opacities (GGO) bilateral or unilateral. We compared the" exact="bilateral" post="lesion of the mild group 63/95 (66.3%) to with"/>
 <result pre="symptom and serum biochemical examination Variables All (nâ€‰=â€‰123) Mild (nâ€‰=â€‰95)" exact="Severe" post="(nâ€‰=â€‰28) P Characteristic â€ƒAge (years) 37 (7) 35 (6)"/>
 <result pre="0.706 â€ƒDiarrhea 13/123 (10.6%) 9/95 (9.5%) 4/28 (14.3%) 0.467 â€ƒCT" exact="Bilateral" post="Lesion 84/123 (68.3%) 63/95 (66.3%) 21/28 (75%) 0.385 â€ƒPreadmission"/>
 <result pre="D-dimer (mild 0 cases, severe 1case). Where N is the" exact="total" post="number of patients with available data. P values comparing"/>
 <result pre="PLT platelet, PT prothrombin time, RBC red blood cell, TBIL" exact="total" post="bilirubin, Temp temperature, WBC white blood cell Biochemical examination"/>
 <result pre="1.385 0.254 7.556 0.707 â€ƒDiarrhea 1.593 0.451 5.624 0.470 â€ƒCT" exact="Bilateral" post="Lesion 1.524 0.586 3.961 0.388 â€ƒPreadmission drugs 0.651 0.267"/>
 <result pre="PLT platelet, PT prothrombin time, RBC red blood cell, TBIL" exact="total" post="bilirubin, Temp temperature, WBC white blood cell Table 3"/>
 <result pre="Variables OR 95% CI P Age 1.065 0.986 1.150 0.108" exact="Fever" post="2.472 0.136 44.840 0.540 Temp 0.724 0.323 1.622 0.432"/>
 <result pre="Temp temperature Fig. 2 Lymphocyte count for severe progressed coronavirus" exact="disease" post="in previously healthy adults using receiver operating characteristic curves."/>
 <result pre="outbreaks, fever and cough were the most common symptoms with" exact="viral pneumonia" post="[9]. Our study showed that patients with severe COVID-19"/>
 <result pre="fever and cough were the most common symptoms with viral" exact="pneumonia" post="[9]. Our study showed that patients with severe COVID-19"/>
 <result pre="adults with sound immunity, the occurrence of high fever after" exact="viral infection" post="indicates the bodyâ€™s rapid response against the invaded pathogen."/>
 <result pre="with sound immunity, the occurrence of high fever after viral" exact="infection" post="indicates the bodyâ€™s rapid response against the invaded pathogen."/>
 <result pre="fever (PÂ =â€‰0.001). The previous study showed that dyspnea and" exact="chest" post="tightness were indicators of severe COVID-19 [10]. Inversely, we"/>
 <result pre="in the mild group) had dyspnea and 39 patients had" exact="chest" post="tightness (11 in the severe group and 28 in"/>
 <result pre="the lungs, we inferred that there was less probability of" exact="respiratory" post="decompensation on admission. Besides, a great sample size was"/>
 <result pre="older patients would need to beware of aggravation of the" exact="disease" post="because an older age indicates the decline in organ"/>
 <result pre="rate of COVID-19 severity in patients was 22.76%, which was" exact="lower" post="than that of the previous study [11]. This is"/>
 <result pre="invading pathogens and viruses. However, the reasons they quickly develop" exact="respiratory" post="failure or acute respiratory distress syndrome (ARDS) after being"/>
 <result pre="viruses. However, the reasons they quickly develop respiratory failure or" exact="acute" post="respiratory distress syndrome (ARDS) after being infected with SARS-Co-2"/>
 <result pre="However, the reasons they quickly develop respiratory failure or acute" exact="respiratory" post="distress syndrome (ARDS) after being infected with SARS-Co-2 are"/>
 <result pre="reasons they quickly develop respiratory failure or acute respiratory distress" exact="syndrome" post="(ARDS) after being infected with SARS-Co-2 are still unclear."/>
 <result pre="first reason is possibly attributed to the pathophysiology of the" exact="viral" post="load. Tiny viral loads allow the immune system to"/>
 <result pre="possibly attributed to the pathophysiology of the viral load. Tiny" exact="viral" post="loads allow the immune system to produce antibodies whether"/>
 <result pre="a significant number of viruses invade the body in a" exact="short" post="time, the immune system will be overwhelmed, resulting in"/>
 <result pre="damages the lungâ€™s tiny vessels. It will subsequently result in" exact="pulmonary" post="edema, providing significant burden to the circulatory system, eventually"/>
 <result pre="providing significant burden to the circulatory system, eventually crushing the" exact="heart" post="and lungs as well as causing coagulation and massive"/>
 <result pre="body. Recently, Zou et al. have proven the presence of" exact="viral" post="load of the upper respiratory tract that was detected"/>
 <result pre="al. have proven the presence of viral load of the" exact="upper" post="respiratory tract that was detected in the asymptomatic patient"/>
 <result pre="have proven the presence of viral load of the upper" exact="respiratory" post="tract that was detected in the asymptomatic patient was"/>
 <result pre="in the asymptomatic patient was similar to that in the" exact="symptomatic" post="patients [13]. According to another previous study, the lower"/>
 <result pre="the symptomatic patients [13]. According to another previous study, the" exact="lower" post="respiratory tract specimens usually have significantly higher viral loads"/>
 <result pre="symptomatic patients [13]. According to another previous study, the lower" exact="respiratory" post="tract specimens usually have significantly higher viral loads and"/>
 <result pre="study, the lower respiratory tract specimens usually have significantly higher" exact="viral" post="loads and genome fractions than the upper respiratory tract"/>
 <result pre="have significantly higher viral loads and genome fractions than the" exact="upper" post="respiratory tract specimens [14]. The second reason is possibly"/>
 <result pre="significantly higher viral loads and genome fractions than the upper" exact="respiratory" post="tract specimens [14]. The second reason is possibly attributed"/>
 <result pre="was widely used as a biochemical indicator for reflecting the" exact="acute" post="severe systemic inflammatory response caused by a viral infection,"/>
 <result pre="used as a biochemical indicator for reflecting the acute severe" exact="systemic" post="inflammatory response caused by a viral infection, such that"/>
 <result pre="reflecting the acute severe systemic inflammatory response caused by a" exact="viral infection," post="such that our research illustrated that the severe COVID-19"/>
 <result pre="was widely administered in the treatment of SARS to control" exact="pulmonary" post="inflammatory edema by regulating the immunity responses toward SARS-CoV."/>
 <result pre="recently, most studies have reported that corticosteroids could only delay" exact="viral" post="clearance [16] and are insignificantly associated with the mortality"/>
 <result pre="and are insignificantly associated with the mortality rate in severe" exact="viral pneumonia" post="[17]. According to Wang et al.â€™s study [18] in"/>
 <result pre="are insignificantly associated with the mortality rate in severe viral" exact="pneumonia" post="[17]. According to Wang et al.â€™s study [18] in"/>
 <result pre="is administered at the right time with a reasonable dose." exact="Elevated" post="D-dimer levels in COVID-19 patients, associated with poor clinical"/>
 <result pre="[19]. Tiny thromboses are produced by inflammatory cascade, blocking the" exact="pulmonary" post="vessel, which might result in disseminated intravascular coagulation (DIC)"/>
 <result pre="inflammatory cascade, blocking the pulmonary vessel, which might result in" exact="disseminated intravascular coagulation" post="(DIC) without stopping inflammation. In fact, in clinical practice,"/>
 <result pre="in clinical practice, low-molecular-weight heparin (LMWH) is administered to prevent" exact="thrombosis" post="if the D-dimer levels at &amp;gt;â€‰4â€‰Î¼g/ml. The inflammatory reaction"/>
 <result pre="compensation before D-dimer elevating. Lymphopenia is commonly assessed in most" exact="viral" post="infections, specifically, type A and B influenza [20]. According"/>
 <result pre="elevating. Lymphopenia is commonly assessed in most viral infections, specifically," exact="type A" post="and B influenza [20]. According to a previous study,"/>
 <result pre="A and B influenza [20]. According to a previous study," exact="lymphopenia" post="was also observed in SARS and MERS [21]. Coronavirus"/>
 <result pre="lymphopenia was also observed in SARS and MERS [21]. Coronavirus" exact="infection" post="usually induces an immune response, resulting in decreased CD4"/>
 <result pre="and immunosuppression [22, 23]. Simultaneously, the virus also damages the" exact="epithelial" post="walls, and disrupts surfactant in the airways, providing access"/>
 <result pre="and disrupts surfactant in the airways, providing access to rapid" exact="bacterial" post="growth and resulting in a secondary bacterial infection, adversely"/>
 <result pre="providing access to rapid bacterial growth and resulting in a" exact="secondary" post="bacterial infection, adversely affecting immunosuppressed patients. Our study also"/>
 <result pre="access to rapid bacterial growth and resulting in a secondary" exact="bacterial infection," post="adversely affecting immunosuppressed patients. Our study also has limitations."/>
 <result pre="limitations. Firstly, considering this was a single-center, retrospective study with" exact="limited" post="sample size, avoiding bias regarding patient distribution is considered"/>
 <result pre="size, avoiding bias regarding patient distribution is considered difficult. Secondly," exact="lymphopenia" post="was observed in contribution to severe prognosis in this"/>
 <result pre="is then more likely to progress to severe COVID-19. Furthermore," exact="lymphopenia" post="was considered as the strongest predictor of severe prognosis."/>
 <result pre="for physicians to comprehensively understand the predictive factors associated with" exact="disease" post="severity for COVID-19, allowing them to immediately and accurately"/>
 <result pre="accurately provide supportive treatment, preventing the rapid development of the" exact="disease" post="and decreasing the mortality rate. However, additional multicenter, prospective"/>
 <result pre="assess the clinical outcomes of severe COVID-19. Conclusion In conclusion," exact="lymphopenia" post="is considered the strongest predictor of severe prognosis in"/>
 <result pre="Abbreviations ALB Albumin ALT Alanine transaminase AST Aspartate transaminase ARDS" exact="Acute" post="Respiratory Distress Syndrome AUC Area under the receiver operating"/>
 <result pre="ALB Albumin ALT Alanine transaminase AST Aspartate transaminase ARDS Acute" exact="Respiratory" post="Distress Syndrome AUC Area under the receiver operating characteristic"/>
 <result pre="ALT Alanine transaminase AST Aspartate transaminase ARDS Acute Respiratory Distress" exact="Syndrome" post="AUC Area under the receiver operating characteristic curve BUN"/>
 <result pre="Syndrome AUC Area under the receiver operating characteristic curve BUN" exact="Blood" post="urea nitrogen CI Confidence interval CK Creatine kinase CK-MB"/>
 <result pre="Cr Creatinine CRP C-reactive protein CT Computed tomography COVID-19 Coronavirus" exact="Disease" post="2019 DBIL Direct bilirubin ECMO Extracorporeal membrane oxygenation Fib"/>
 <result pre="Ground-glass opacity HFNC High-flow nasal cannula IBIL Indirect bilirubin DIC" exact="Disseminated" post="intravascular coagulation ICU Intensive care unit INR International normalized"/>
 <result pre="ranges L Lymphocyte count LMWH Low-molecular-weight heparin MERS-COV Middle East" exact="respiratory" post="syndrome coronavirus N Neutrophil count N% Neutrophil% NPPV Noninvasive"/>
 <result pre="L Lymphocyte count LMWH Low-molecular-weight heparin MERS-COV Middle East respiratory" exact="syndrome" post="coronavirus N Neutrophil count N% Neutrophil% NPPV Noninvasive positive-pressure"/>
 <result pre="East respiratory syndrome coronavirus N Neutrophil count N% Neutrophil% NPPV" exact="Noninvasive" post="positive-pressure ventilation OR Odds ratio PLT Platelet PT Prothrombin"/>
 <result pre="N% Neutrophil% NPPV Noninvasive positive-pressure ventilation OR Odds ratio PLT" exact="Platelet" post="PT Prothrombin time RBC Red blood cell ROC Receiver"/>
 <result pre="time RBC Red blood cell ROC Receiver operating characteristic SARS-CoV" exact="Severe" post="acute respiratory syndrome coronavirus SARS-CoV-2 Severe acute respiratory syndrome"/>
 <result pre="RBC Red blood cell ROC Receiver operating characteristic SARS-CoV Severe" exact="acute" post="respiratory syndrome coronavirus SARS-CoV-2 Severe acute respiratory syndrome coronavirus"/>
 <result pre="Red blood cell ROC Receiver operating characteristic SARS-CoV Severe acute" exact="respiratory" post="syndrome coronavirus SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2"/>
 <result pre="blood cell ROC Receiver operating characteristic SARS-CoV Severe acute respiratory" exact="syndrome" post="coronavirus SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 SPSS"/>
 <result pre="Receiver operating characteristic SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2" exact="Severe" post="acute respiratory syndrome coronavirus 2 SPSS Statistical Package for"/>
 <result pre="operating characteristic SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2 Severe" exact="acute" post="respiratory syndrome coronavirus 2 SPSS Statistical Package for the"/>
 <result pre="characteristic SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2 Severe acute" exact="respiratory" post="syndrome coronavirus 2 SPSS Statistical Package for the Social"/>
 <result pre="SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2 Severe acute respiratory" exact="syndrome" post="coronavirus 2 SPSS Statistical Package for the Social Sciences"/>
 <result pre="2 SPSS Statistical Package for the Social Sciences Statistic TBIL" exact="Total" post="bilirubin Temp Temperature WBC White blood cell WHO World"/>
 <result pre="This study was approved by the Ethics Committee of the" exact="Central" post="Hospital of Wuhan. [Yuan lun han (2020) No. 56]."/>
 <result pre="have no competing interests. References References 1.JiangSDuLShiZAn emerging coronavirus causing" exact="pneumonia" post="outbreak in Wuhan, China: calling for developing therapeutic and"/>
 <result pre="developing therapeutic and prophylactic strategiesEmerg Microbes Infect2020927527710.1080/22221751.2020.172344132005086 2.collab: Organization WHCoronavirus" exact="disease" post="2019 (COVID-19): situation report, 742020 3.de WitEvan DoremalenNFalzaranoDMunsterVJSARS and"/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 6.World Health Organization."/>
 <result pre="a descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 6.World Health Organization. Clinical management of severe" exact="acute" post="respiratory infection when novel coronavirus (nCoV) infection is suspected:"/>
 <result pre="descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 6.World Health Organization. Clinical management of severe acute" exact="respiratory" post="infection when novel coronavirus (nCoV) infection is suspected: interim"/>
 <result pre="studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 6.World Health Organization. Clinical management of severe acute respiratory" exact="infection" post="when novel coronavirus (nCoV) infection is suspected: interim guidance."/>
 <result pre="management of severe acute respiratory infection when novel coronavirus (nCoV)" exact="infection" post="is suspected: interim guidance. Published January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected."/>
 <result pre="&quot;guidelines for the diagnosis and treatment of novel coronavirus (2019-nCoV)" exact="infection" post="by the National Health Commission (trial version 5)&quot;Zhonghua Yi"/>
 <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, China. JAMA. 2020;323:1061. 11.Zhang JJ, Dong X,"/>
 <result pre="Wuhan, 454 China. Allergy. 2020. Advance online publication. 12.LeeHKTsoEYChauTNTsangOTChoiKWLaiTSAsymptomatic severe" exact="acute" post="respiratory syndrome-associated coronavirus infectionEmerg Infect Dis200391491149210.3201/eid0911.03040114725258 13.ZouLRuanFHuangMLiangLHuangHHongZYuJKangMSongYXiaJet al.SARS-CoV-2 viral"/>
 <result pre="454 China. Allergy. 2020. Advance online publication. 12.LeeHKTsoEYChauTNTsangOTChoiKWLaiTSAsymptomatic severe acute" exact="respiratory" post="syndrome-associated coronavirus infectionEmerg Infect Dis200391491149210.3201/eid0911.03040114725258 13.ZouLRuanFHuangMLiangLHuangHHongZYuJKangMSongYXiaJet al.SARS-CoV-2 viral load"/>
 <result pre="severe acute respiratory syndrome-associated coronavirus infectionEmerg Infect Dis200391491149210.3201/eid0911.03040114725258 13.ZouLRuanFHuangMLiangLHuangHHongZYuJKangMSongYXiaJet al.SARS-CoV-2" exact="viral" post="load in upper respiratory specimens of infected patientsN Engl"/>
 <result pre="syndrome-associated coronavirus infectionEmerg Infect Dis200391491149210.3201/eid0911.03040114725258 13.ZouLRuanFHuangMLiangLHuangHHongZYuJKangMSongYXiaJet al.SARS-CoV-2 viral load in" exact="upper" post="respiratory specimens of infected patientsN Engl J Med20203821177117910.1056/NEJMc200173732074444 14.MemishZAAl-TawfiqJAMakhdoomHQAssiriAAlhakeemRFAlbarrakAAlsubaieSAl-RabeeahAAHajomarWHHussainRet"/>
 <result pre="coronavirus infectionEmerg Infect Dis200391491149210.3201/eid0911.03040114725258 13.ZouLRuanFHuangMLiangLHuangHHongZYuJKangMSongYXiaJet al.SARS-CoV-2 viral load in upper" exact="respiratory" post="specimens of infected patientsN Engl J Med20203821177117910.1056/NEJMc200173732074444 14.MemishZAAl-TawfiqJAMakhdoomHQAssiriAAlhakeemRFAlbarrakAAlsubaieSAl-RabeeahAAHajomarWHHussainRet al.Respiratory"/>
 <result pre="of infected patientsN Engl J Med20203821177117910.1056/NEJMc200173732074444 14.MemishZAAl-TawfiqJAMakhdoomHQAssiriAAlhakeemRFAlbarrakAAlsubaieSAl-RabeeahAAHajomarWHHussainRet al.Respiratory tract samples," exact="viral" post="load, and genome fraction yield in patients with Middle"/>
 <result pre="load, and genome fraction yield in patients with Middle East" exact="respiratory" post="syndromeJ Infect Dis20142101590159410.1093/infdis/jiu29224837403 15.RussellCDMillarJEBaillieJKClinical evidence does not support corticosteroid"/>
 <result pre="early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in" exact="adult" post="patientsJ Clin Virol20043130430910.1016/j.jcv.2004.07.00615494274 17.ArabiYMMandourahYAl-HameedFSindiAAAlmekhlafiGAHusseinMAJoseJPintoRAl-OmariAKharabaAet al.Corticosteroid therapy for critically ill"/>
 <result pre="17.ArabiYMMandourahYAl-HameedFSindiAAAlmekhlafiGAHusseinMAJoseJPintoRAl-OmariAKharabaAet al.Corticosteroid therapy for critically ill patients with Middle East" exact="respiratory" post="syndromeAm J Respir Crit Care Med201819775776710.1164/rccm.201706-1172OC29161116 18.Wang Y, Jiang"/>
 <result pre="10.1101/2020.03.06.20032342. 19.ZhouFYuTDuRFanGLiuYLiuZXiangJWangYSongBGuXet al.Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China: a retrospective cohort"/>
 <result pre="cohort studyLancet20203951054106210.1016/S0140-6736(20)30566-332171076 20.BellelliVd'EttorreGCelaniLBorrazzoCCeccarelliGVendittiMClinical significance of lymphocytopenia in patients hospitalized with" exact="pneumonia" post="caused by influenza virusCrit Care20192333010.1186/s13054-019-2608-131665060 21.YinYWunderinkRGMERS, SARS and other"/>
 <result pre="and other coronaviruses as causes of pneumoniaRespirology20182313013710.1111/resp.1319629052924 22.HeZZhaoCDongQZhuangHSongSPengGDwyerDEEffects of severe" exact="acute" post="respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes"/>
 <result pre="other coronaviruses as causes of pneumoniaRespirology20182313013710.1111/resp.1319629052924 22.HeZZhaoCDongQZhuangHSongSPengGDwyerDEEffects of severe acute" exact="respiratory" post="syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and"/>
 <result pre="coronaviruses as causes of pneumoniaRespirology20182313013710.1111/resp.1319629052924 22.HeZZhaoCDongQZhuangHSongSPengGDwyerDEEffects of severe acute respiratory" exact="syndrome" post="(SARS) coronavirus infection on peripheral blood lymphocytes and their"/>
 <result pre="of pneumoniaRespirology20182313013710.1111/resp.1319629052924 22.HeZZhaoCDongQZhuangHSongSPengGDwyerDEEffects of severe acute respiratory syndrome (SARS) coronavirus" exact="infection" post="on peripheral blood lymphocytes and their subsetsInt J Infect"/>
 <result pre="22.HeZZhaoCDongQZhuangHSongSPengGDwyerDEEffects of severe acute respiratory syndrome (SARS) coronavirus infection on" exact="peripheral" post="blood lymphocytes and their subsetsInt J Infect Dis2005932333010.1016/j.ijid.2004.07.01416095942 23.KoJHParkGELeeJYLeeJYChoSYHaYEKangCIKangJMKimYJHuhHJet"/>
 <result pre="and their subsetsInt J Infect Dis2005932333010.1016/j.ijid.2004.07.01416095942 23.KoJHParkGELeeJYLeeJYChoSYHaYEKangCIKangJMKimYJHuhHJet al.Predictive factors for" exact="pneumonia" post="development and progression to respiratory failure in MERS-CoV infected"/>
 <result pre="Dis2005932333010.1016/j.ijid.2004.07.01416095942 23.KoJHParkGELeeJYLeeJYChoSYHaYEKangCIKangJMKimYJHuhHJet al.Predictive factors for pneumonia development and progression to" exact="respiratory" post="failure in MERS-CoV infected patientsJ Inf Secur201673468475"/>
</results>
